perifosine has been researched along with Cholera Infantum in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beijnen, JH; Crul, M; de Klerk, GJ; Dubbelman, R; Knebel, NG; Reichert, S; Rosing, H; Schellens, JH; ten Bokkel Huinink, WW; Traiser, M | 1 |
1 trial(s) available for perifosine and Cholera Infantum
Article | Year |
---|---|
Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Humans; Male; Maximum Allowable Concentration; Middle Aged; Neoplasms; Phosphorylcholine | 2002 |